Filing Details
- Accession Number:
- 0001209191-16-093116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-22 16:20:59
- Reporting Period:
- 2016-01-20
- Filing Date:
- 2016-01-22
- Accepted Time:
- 2016-01-22 16:20:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-01-20 | 10,400 | $35.64 | 275,684 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-01-20 | 1,100 | $90.46 | 274,584 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-20 | 2,200 | $91.87 | 272,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-20 | 2,000 | $92.87 | 270,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-20 | 1,300 | $93.71 | 269,084 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-20 | 1,900 | $95.24 | 267,184 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-20 | 800 | $96.18 | 266,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-20 | 1,000 | $97.46 | 265,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-20 | 100 | $98.46 | 265,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-01-20 | 10,400 | $0.00 | 10,400 | $35.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,200 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401k |
| Common Stock | 122,700 | Indirect | Common Stock Held In Trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $90.46 (range $90.23 to $90.60).
- Open market sales reported on this line occurred at a weighted average price of $91.87 (range $91.37 to $92.33).
- Open market sales reported on this line occurred at a weighted average price of $92.87 (range $92.46 to $93.28).
- Open market sales reported on this line occurred at a weighted average price of $93.71 (range $93.46 to $93.89).
- Open market sales reported on this line occurred at a weighted average price of $95.24 (range $94.68 to $95.64).
- Open market sales reported on this line occurred at a weighted average price of $96.18 (range $95.73 to $96.69).
- Open market sales reported on this line occurred at a weighted average price of $97.46 (range $97.12 to $97.61).
- Fully vested.
Billionaire Hedge Funds
